
Dr. Werner Engelbrecht, senior director strategy, Veeva Systems explores how this year could see clinical trial innovation surge as EU regulation evolves.
Europe’s clinical trial regulations are evolving fast. Policies including the EU General Data Protection Regulation (GDPR), the AI Act, ACT EU and the soon-to-launch European Biotechnology law are redefining clinical trial standards. Biopharma companies must now balance compliance with innovation, navigating a landscape that demands both transparency and technological agility.
In a 2024 address, the European Commission…